Sharechat Logo

Rakon shares drop 4.6 percent as 2014 loss widens to $79.9 million on asset writedowns, depreciation

Thursday 8th May 2014

Text too small?

Shares in Rakon dropped 4.6 percent, making the stock the second-worst performer on the NZX All Ordinaries Index, after the maker of crystal oscillators used in smart phones and navigation systems said it lost more than it expected last year as its assets fell in value.

The Auckland-based company said it had a loss of $79.9 million in the year ended March 31, wider than its forecast loss of between $55 million to $59 million, and its $32.8 million loss the year earlier. The latest figures are unaudited and the company said its full earnings will be released May 22.

Rakon expects to write down the goodwill of its UK factory by $15 million as part of a plan to shift manufacturing to New Zealand in the current financial year. In addition, other property, plant and equipment was assessed as having a reduced useful life, bringing forward depreciation of $7.4 million and the company has also finalised the impairment following the sale of most of its stake in its Chinese factory to repay debt.

Shares in Rakon dropped 1 cent to 21 cents, taking their slide over the past year to 8.7 percent.

The company said its expectation for a 2014 loss in 'underlying' earnings before interest, tax, depreciation and amortisation remains unchanged of $5 million to $8 million.

Meantime, it met its target of reducing bank borrowings below $12 million at March 31, Rakon said.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors